Oncopro Hereditary Cancer Risk Panel Screens 200 Genes Test
Introduction
The Oncopro Hereditary Cancer Risk Panel Screens 200 Genes Test is a state-of-the-art diagnostic tool designed for individuals at risk of hereditary cancers. This comprehensive test utilizes Next Generation Sequencing (NGS) technology to analyze 200 genes associated with increased cancer risk, enabling early detection and proactive management of potential health issues.
What the Test Measures
This test screens for mutations in genes that are known to contribute to hereditary cancer syndromes. It includes critical genes such as BRCA1, BRCA2, and many others that play a vital role in cancer development. By identifying these mutations, healthcare providers can better assess a patient’s risk for various cancers, including breast, ovarian, and colorectal cancers.
Who Should Consider This Test?
Individuals with a significant family history of cancer, particularly those with:
- Multiple family members diagnosed with cancer
- Early onset of cancer in family members
- Known genetic mutations in the family
Additionally, patients experiencing symptoms related to hereditary cancer syndromes should discuss the test with their oncologist.
Benefits of Taking the Test
- Identifies genetic predisposition to cancer.
- Informs personalized prevention and treatment strategies.
- Empowers individuals with knowledge about their health risks.
- Facilitates informed decision-making regarding screening and surveillance.
Understanding Your Results
Results from the Oncopro Hereditary Cancer Risk Panel will indicate whether any mutations were detected. A positive result may suggest an increased risk for certain cancers, while a negative result can provide peace of mind. It is essential to discuss results with a qualified healthcare provider to understand the implications fully.
Test Name and Price
| Discount Price | Regular Price |
|---|---|
| 65,520 KSh | 72,800 KSh |
Pre-Test Instructions
Please ensure a duly filled Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) is submitted with your sample. The sample type required is 10 mL (8 mL min.) of whole blood in a Lavender Top (EDTA) tube, which should be shipped immediately at 18°C to 22°C. DO NOT refrigerate or freeze the sample.
Branches and Booking
We have branches across major cities in Kenya, making it convenient for you to access our services. To book the Oncopro Hereditary Cancer Risk Panel Screens 200 Genes Test or for more information, please call or WhatsApp us at +254711564616. Take the first step towards understanding your health today!
